Miller Joseph M
SEC insider (Form 3/4/5 filer). CIK 0001746372. Chief Financial Officer at LB PHARMACEUTICALS INC (LBRX) and 1 other issuer. 10 reported Form 4/5 transactions since Sep 2024; latest on Oct 9, 2026. Located in NEW YORK, NY.
Companies Miller Joseph M has filed insider reports for
- LB PHARMACEUTICALS INC (LBRX): Officer, Chief Financial Officer
- Aurinia Pharmaceuticals Inc. (AUPH): Officer, Chief Financial Officer
Miller Joseph M
CIK: 0001746372
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- Oct 9, 2026LBRX
LB PHARMACEUTICALS INC
AwardDirectEmplopyee Stock Option (Right to Buy)
200K shares- - Mar 2, 2026AUPH
Aurinia Pharmaceuticals Inc.
Tax PaymentDirect37.5K shares at avg. $14.21$533K - Feb 27, 2026AUPH
Aurinia Pharmaceuticals Inc.
AwardDirect57.2K shares- - Feb 20, 2026AUPH
Aurinia Pharmaceuticals Inc.
Tax PaymentDirect32.4K shares at avg. $14.40$467K - Jan 2, 2026AUPH
Aurinia Pharmaceuticals Inc.
Tax PaymentDirect40.2K shares at avg. $15.95$641K - Jan 2, 2026AUPH
Aurinia Pharmaceuticals Inc.
AwardDirect49K shares- - Mar 4, 2025AUPH
Aurinia Pharmaceuticals Inc.
SaleDirect56.2K shares at avg. $7.92$445K - Mar 3, 2025AUPH
Aurinia Pharmaceuticals Inc.
AwardDirect114.7K shares- - Mar 3, 2025AUPH
Aurinia Pharmaceuticals Inc.
SaleDirect61.9K shares at avg. $8.00$495K - Feb 28, 2025AUPH
Aurinia Pharmaceuticals Inc.
AwardDirect81.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 9, 2026 |  LBRX LB PHARMACEUTICALS INC | Award Emplopyee Stock Option (Right to Buy) | 200,000 | - | - | Direct |
| Mar 2, 2026 |  AUPH Aurinia Pharmaceuticals Inc. | Tax Payment | 37,511 | $14.21 | $533,031 | Direct |
| Feb 27, 2026 | AUPH Aurinia Pharmaceuticals Inc. | Award | 57,229 | - | $0 | Direct |
| Feb 20, 2026 | AUPH Aurinia Pharmaceuticals Inc. | Tax Payment | 32,424 | $14.40 | $466,906 | Direct |
| Jan 2, 2026 | AUPH Aurinia Pharmaceuticals Inc. | Tax Payment | 40,161 | $15.95 | $640,568 | Direct |
| Jan 2, 2026 | AUPH Aurinia Pharmaceuticals Inc. | Award | 49,038 | - | $0 | Direct |
| Mar 4, 2025 | AUPH Aurinia Pharmaceuticals Inc. | Sale | 56,154 | $7.92 | $444,740 | Direct |
| Mar 3, 2025 | AUPH Aurinia Pharmaceuticals Inc. | Award | 114,711 | - | - | Direct |
| Mar 3, 2025 | AUPH Aurinia Pharmaceuticals Inc. | Sale | 61,859 | $8.00 | $494,872 | Direct |
| Feb 28, 2025 | AUPH Aurinia Pharmaceuticals Inc. | Award | 81,457 | - | - | Direct |
1-10 of 10 transactions